CD24 and glioblastoma: However, cancer initiating cells in other neoplasms have been characterized by at least 2 different surface markers; CD44+/CD24-/lin- in breast cancer, a2b5+/CD133- in glioblastoma and CD34+/CD38− in leukemia: [43].